The only biotechnology enterprise in Central America
The first experience of technology transfer of production of Russian influenza vaccine
The production complies with international quality standards GMP
A unique platform for Russian and international manufacturers to enter the markets of Latin America and Caribbean (LAC)
A production capacity up to 60 million doses of sterile products per year
In 2025, the vaccine «Flu-M», jointly produced by FSUE SPbSRIVS FMBA of Russia and Instituto Mechnikov, S.A. received WHO prequalification status
